Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F1GMH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,890
Award facts
- Contract value 100% obligated
- $40,889.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,889.83 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen medications on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price contract is not set-aside and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. SKYRIZI is a biologic treatment used in dermatology for conditions such as psoriasis and psoriatic arthritis. As a non-set-aside, competitively awarded contract, this delivery order demonstrates AmerisourceBergen's continued capability to meet federal pharmaceutical procurement requirements and support the Defense Health Agency and military treatment facilities through the DLA Troop Support Medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F1GMH?
SPE2DR26F1GMH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F1GMH worth?
The government has obligated $40,890 on SPE2DR26F1GMH.
Is contract SPE2DR26F1GMH an order under another contract?
Yes. SPE2DR26F1GMH is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GMH competed?
The extent of competition for SPE2DR26F1GMH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award